- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Venus Medtech (Hangzhou) Inc.: Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations | 286 | PR Newswire | HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart... ► Artikel lesen | |
| 28.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 | - | HKEx | ||
| 20.03. | VENUS MEDTECH-B (02500): PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 2 | HKEx | ||
| 18.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | - | HKEx | ||
| 14.03. | China's Venus Medtech Goes Live Again With 69% Plunge After Embezzlement | 1 | Yicai Global | ||
| 12.03. | VENUS MEDTECH-B (02500): FULFILLMENT OF ALL RESUMPTION GUIDANCE AND RESUMPTION OF TRADING | 1 | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 21.02. | VENUS MEDTECH-B (02500): (1) THE FIFTH QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING | 3 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): ARTICLES OF ASSOCIATION | - | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 05.12.24 | VENUS MEDTECH-B (02500): POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING, 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES AND 2024 SECOND ... | - | HKEx | ||
| 22.11.24 | VENUS MEDTECH-B (02500): (1) THE FOURTH QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING | 1 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF CIRCULAR, PROXY FORM OF EXTRAORDINARY GENERAL MEETING ... | - | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF CIRCULAR, PROXY FORM OF EXTRAORDINARY GENERAL MEETING ... | - | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 SECOND CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES | 2 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES | 1 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTICE OF 2024 SECOND CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES | 1 | HKEx | ||
| 19.11.24 | VENUS MEDTECH-B (02500): NOTICE OF 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES | - | HKEx |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 55,76 | 0,00 % | Piper Sandler maintains $100 target on Procept BioRobotics stock | ||
| GENEDX | 105,93 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
| SIEMENS HEALTHINEERS | 45,970 | +0,75 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,295 | +0,74 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
| FRESENIUS | 39,390 | -0,23 % | Fresenius SE Aktie: Leichte Erholung im Fokus | Fresenius notiert nahe dem Jahreshoch mit soliden technischen und fundamentalen Signalen. Analysten sehen weiteres Kurspotenzial trotz hoher Verschuldung. Die Fresenius-Aktie zeigt sich am Donnerstag... ► Artikel lesen | |
| GERRESHEIMER | 53,20 | +2,01 % | Leichte Zugewinne bei der Gerresheimer-Aktie (51,60 €) | Im Plus liegt aktuell die Gerresheimer-Aktie . Zuletzt zahlten Investoren für das Papier 51,60 Euro. Für die Aktie von Gerresheimer steht gegenwärtig ein Wertanstieg 1,57 Prozent zu Buche. Das Wertpapier... ► Artikel lesen | |
| ATRICURE | 32,505 | +1,67 % | EG-ATRC, ITU Academy Host Global Spectrum Monitoring Training | ||
| BRIGHTSPRING HEALTH SERVICES | 16,270 | +1,12 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ADAPTHEALTH | 7,715 | 0,00 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 21,250 | -3,32 % | Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary... ► Artikel lesen | |
| NUTEX HEALTH | 143,06 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
| NANO-X IMAGING | 5,105 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X | First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicationsEnhanced imaging system features sleek... ► Artikel lesen | |
| RXSIGHT | 14,470 | +1,19 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| AGILON HEALTH | 3,915 | 0,00 % | agilon health Reports Third Quarter 2024 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter... ► Artikel lesen | |
| UNITEDHEALTH | 378,60 | +0,33 % | Dow Jones: UnitedHealth-Schock! | News von Trading-Treff.de Schwere Zeiten für den Dow Jones. Die Aktie der UnitedHealth Group (UNH) stürzt ab und zieht den gesamten Index mit nach unten. Am heutigen Donnerstag fiel der Index um 1,01... ► Artikel lesen |
Das Unternehmen VENUS MEDTECH HANGZHOU INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.
